Itopride Tablets (Itopride Hydrochloride)

Adult dose

○ Adults: Administer itopride hydrochloride 50 mg orally 3 times daily before meals. Reduce the dose appropriately according to symptoms.

This medication should not be used in patients who have had an allergic reaction to this medication or any of its ingredients. It should also not be administered to patients for whom stimulating gastrointestinal motility could be harmful, such as patients with gastrointestinal bleeding, mechanical obstruction, or perforation. This medication contains lactose, so it should not be given to patients with inherited disorders that cause lactose intolerance. When using this medication, serious allergic reactions such as shock or anaphylaxis may occur, so symptoms should be monitored carefully. Liver function impairment or jaundice symptoms may occur, so liver status should be observed closely. Gastrointestinal symptoms such as nausea, diarrhea, constipation, abdominal pain, and increased salivation may occur. Psychoneurological symptoms such as headache, anxiety, sleep problems, and dizziness may also be experienced. Endocrine abnormalities such as gynecomastia or elevated prolactin levels may occur, so if unusual symptoms arise, use should be discontinued. Blood-related abnormalities such as thrombocytopenia or leukopenia may occur, and blood tests should be conducted to monitor the condition. Kidney function may be affected, so it is advisable to regularly check BUN and creatinine levels. Liver enzyme levels may increase, necessitating liver function tests. Rarely, hypersensitivity reactions such as skin rash, redness, and itching may occur, so if unusual symptoms present, treatment should be stopped. Extrapyramidal symptoms such as tremors may occur, and if symptoms appear, use must be discontinued. Chest or back pain and fatigue may occur, so these symptoms should also be monitored closely. This medication enhances the action of acetylcholine, so caution is needed when used with other drugs that may be affected. If gastrointestinal symptoms do not improve, long-term use is not recommended. Co-administration with anticholinergic drugs may reduce the effectiveness of this medication, so the dosing interval should be adjusted carefully. Pregnant women or women who may become pregnant should only use this medication when the benefits outweigh the risks, as its safety has not been established. Nursing mothers should avoid this medication or, if unavoidable, discontinue breastfeeding, as it may pass into breast milk. Safety in pediatric patients has not been sufficiently confirmed, so use should be approached with caution. Elderly patients may experience adverse reactions more easily due to decreased physical function, so symptoms should be closely monitored, and dosage adjustments or temporary cessation should be considered as needed. This medication should be stored out of reach of children, and transferring to another container is not advisable due to quality maintenance and safety concerns.

• Shock
• anaphylactic reaction symptoms
• hypotension
• dyspnea
• laryngeal edema
• urticaria
• pallor
• sweating
• liver dysfunction
• jaundice

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is best stored at a temperature between 1 degree and 30 degrees Celsius.

Appearance

White, round film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 300 tablets/bottle